Your browser doesn't support javascript.
loading
Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.
Harris, Isaac S; Treloar, Aislinn E; Inoue, Satoshi; Sasaki, Masato; Gorrini, Chiara; Lee, Kim Chung; Yung, Ka Yi; Brenner, Dirk; Knobbe-Thomsen, Christiane B; Cox, Maureen A; Elia, Andrew; Berger, Thorsten; Cescon, David W; Adeoye, Adewunmi; Brüstle, Anne; Molyneux, Sam D; Mason, Jacqueline M; Li, Wanda Y; Yamamoto, Kazuo; Wakeham, Andrew; Berman, Hal K; Khokha, Rama; Done, Susan J; Kavanagh, Terrance J; Lam, Ching-Wan; Mak, Tak W.
Afiliação
  • Harris IS; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Medical Biophysics, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Treloar AE; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Medical Biophysics, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Inoue S; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Sasaki M; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Infection and Host Defense, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, Miyagi 981-8558, Japan.
  • Gorrini C; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Lee KC; Department of Pathology, The University of Hong Kong, Hong Kong, China.
  • Yung KY; Department of Pathology, The University of Hong Kong, Hong Kong, China.
  • Brenner D; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Infection and Immunity, Luxembourg Institute of Health, 84, Val Fleuri, 1526 Luxembourg, Luxembourg.
  • Knobbe-Thomsen CB; Department of Neuropathology, Heinrich Heine University, 40225 Düsseldorf, Germany.
  • Cox MA; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Elia A; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Berger T; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Cescon DW; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Medical Biophysics, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Adeoye A; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Laboratory Medicine Program, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Laboratory Medicine and Pathobiology, Uni
  • Brüstle A; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Molyneux SD; Department of Medical Biophysics, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Ontario Cancer Institute, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Mason JM; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Li WY; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Yamamoto K; Division of Cell Function Research Support, Biomedical Research Support Center, Nagasaki University School of Medical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
  • Wakeham A; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Berman HK; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Laboratory Medicine Program, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Laboratory Medicine and Pathobiology, Uni
  • Khokha R; Department of Medical Biophysics, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Ontario Cancer Institute, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada.
  • Done SJ; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Laboratory Medicine Program, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Laboratory Medicine and Pathobiology, Uni
  • Kavanagh TJ; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.
  • Lam CW; Department of Pathology, The University of Hong Kong, Hong Kong, China.
  • Mak TW; The Campbell Family Institute for Breast Cancer Research, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada; Department of Medical Biophysics, University Health Network, 620 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address: tmak@uhnres.utoronto.ca.
Cancer Cell ; 27(2): 211-22, 2015 Feb 09.
Article em En | MEDLINE | ID: mdl-25620030
ABSTRACT
Controversy over the role of antioxidants in cancer has persisted for decades. Here, we demonstrate that synthesis of the antioxidant glutathione (GSH), driven by GCLM, is required for cancer initiation. Genetic loss of Gclm prevents a tumor's ability to drive malignant transformation. Intriguingly, these findings can be replicated using an inhibitor of GSH synthesis, but only if delivered prior to cancer onset, suggesting that at later stages of tumor progression GSH becomes dispensable potentially due to compensation from alternative antioxidant pathways. Remarkably, combined inhibition of GSH and thioredoxin antioxidant pathways leads to a synergistic cancer cell death in vitro and in vivo, demonstrating the importance of these two antioxidants to tumor progression and as potential targets for therapeutic intervention.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Mamárias Animais / Glutamato-Cisteína Ligase / Antioxidantes Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Mamárias Animais / Glutamato-Cisteína Ligase / Antioxidantes Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article